borderline significantp = 0.06
Additionally, there were borderline significant improvements in 5‐year PCSS (83.5% vs. 72.0%; p = 0.06) and OS (71.3% vs. 64.0%; p = 0.1) in patients receiving the SIB technique (Fig. 2 b, d).
Additionally, there were borderline significant improvements in 5‐year PCSS (83.5% vs. 72.0%; p = 0.06) and OS (71.3% vs. 64.0%; p = 0.1) in patients receiving the SIB technique (Fig. 2 b, d).
The multivariable analysis revealed that advanced T stage had borderline significance for predicting worse PCSS, DMFS, and OS.
There has been a clear trend toward the use of novel molecular imaging techniques for staging purposes, specifically gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography ( 68 Ga-PSMA-PET/CT).